Choriocarcinoma (Gestational Trophoblastic Neoplasia) drugs in development, 2023

GlobalData tracks 5 drugs in development for Choriocarcinoma (Gestational Trophoblastic Neoplasia) by four companies/universities/institutes. The top development phase for Choriocarcinoma (Gestational Trophoblastic Neoplasia) is phase i, with four drugs in that stage.

Grifols gears up for FDA approval of fibrinogen replacement therapy

Share this article Grifols plans to file for regulatory approval for the AdFIrst (BT524) in both Europe and the US in Q4 of this year.

February 14, 2024

EHR Data Holds Promise for Chronic Disease Surveillance

What You Should Know: – As chronic disease rates rise across the U.S., researchers are exploring how electronic health records (EHRs) can be used to

December 12, 2023

Podcast #5: Doing Digital Deals in Life Sciences | Deal Structure, Terms, and Series Conclusions – Pharmaceutical Technology

Welcome to the fifth and final episode in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?” Transactions involving digital assets

July 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.